Harry E. Hynes
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Oncology top 5%
- Cancer Treatment and Pharmacology
- Cancer survivorship and care
- Drug Transport and Resistance Mechanisms
- Neutropenia and Cancer Infections
Papers in
- Oncology 19
- Cancer Treatment and Pharmacology 9
- Neutropenia and Cancer Infections 3
- HER2/EGFR in Cancer Research 2
-
- Acute Myeloid Leukemia Research 8
- Co-authors
- Kenneth J. Kopecky (7 shared papers)David R. Head (5 shared papers)Frederick R. Appelbaum (5 shared papers)Jeffrey J. Kirshner (4 shared papers)Cheryl L. Willman (3 shared papers)Patrick J. Flynn (4 shared papers)Gary R. Morrow (4 shared papers)Joseph A. Roscoe (4 shared papers)
- Journals
- Investigational New Drugs (6 papers)Journal of Clinical Oncology (3 papers)Blood (3 papers)Cancer (2 papers)Leukemia Research (2 papers)
- Partner nations
- United States
In The Last Decade
Harry E. Hynes
34 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 100
- Hematology 550
- Oncology 974
- Genetics 135
- Pulmonary and Respiratory Medicine 399
- Biological Psychiatry 27
Countries citing papers authored by Harry E. Hynes
This map shows the geographic impact of Harry E. Hynes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry E. Hynes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry E. Hynes more than expected).
Fields of papers citing papers by Harry E. Hynes
This network shows the impact of papers produced by Harry E. Hynes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry E. Hynes. The network helps show where Harry E. Hynes may publish in the future.
Co-authors
The 25 scholars most cited alongside Harry E. Hynes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1993 | 373 | |
| 2 | 2001 | 301 | |
| 3 | 1998 | 238 | |
| 4 | 2003 | 229 | |
| 5 | 2000 | 209 | |
| 6 | 1998 | 77 | |
| 7 | 1999 | 64 | |
| 8 | 2001 | 62 | |
| 9 | 1997 | 46 | |
| 10 | A prospective evaluation of the roles of allogeneic marrow transplantation and low-dose monthly maintenance chemotherapy in the treatment of adult acute myelogenous leukemia (AML): a Southwest Oncology Group study. | 1995 | 39 |
| 11 | 1993 | 24 | |
| 12 | 1995 | 23 | |
| 13 | 1993 | 21 | |
| 14 | 1991 | 20 | |
| 15 | 1999 | 19 | |
| 16 | A double blind placebo controlled trial of G-CSF in elderly patients with previously untreated acute myeloid leukemia A southwest oncology group study | 1995 | 18 |
| 17 | 1998 | 16 | |
| 18 | 1999 | 15 | |
| 19 | 1992 | 14 | |
| 20 | 1997 | 14 |
About Harry E. Hynes
Harry E. Hynes is a scholar working on Oncology, Hematology, Pulmonary and Respiratory Medicine, Surgery and Molecular Biology, having authored 34 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (9 papers), Acute Myeloid Leukemia Research (8 papers), Chronic Lymphocytic Leukemia Research (4 papers), Acute Lymphoblastic Leukemia research (4 papers), Neutropenia and Cancer Infections (3 papers), Nausea and vomiting management (3 papers), HER2/EGFR in Cancer Research (2 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Hematology (550 citations), Oncology (974 citations), Genetics (135 citations), Pulmonary and Respiratory Medicine (399 citations) and Biological Psychiatry (27 citations). Harry E. Hynes has collaborated with scholars based in United States. Frequent co-authors include Kenneth J. Kopecky, David R. Head, Frederick R. Appelbaum, Jeffrey J. Kirshner, Cheryl L. Willman, Patrick J. Flynn, Gary R. Morrow, Joseph A. Roscoe, Richard F. Raubertas and Richard J. Rosenbluth. Their work appears in journals such as Investigational New Drugs, Journal of Clinical Oncology, Blood, Cancer and Leukemia Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.